BeOne Medicines Expands Hopewell, New Jersey, Operations

Area Development News Desk

07/30/2026

Biopharmaceutical manufacturer BeOne Medicines plans to expand its operations in Hopewell, New Jersey. The $300 million project is expected to create 120 jobs.

The investment will include the construction of a new 145,000-square-foot pharmaceutical manufacturing facility at the company’s existing campus which will serve as a dedicated production hub for small-molecule medicines, complementing the campus's existing biologics manufacturing operations.

“Every patient with cancer deserves innovative, high-quality medicines, and this expansion strengthens our ability to deliver them faster, reliably, and at scale as we work together to stop cancer,” said Aaron Rosenberg, Chief Financial Officer of BeOne Medicines. “Governor Sherrill’s support for this project and the State of New Jersey’s focus on advancing manufacturing were instrumental in making it possible. We are proud to do our part by investing here, growing our team and manufacturing footprint, and continuing to deliver on our commitment to patients in the U.S. and around the world.”

To support the project the New Jersey Economic Development Authority approved a Next New Jersey Manufacturing Program award.

“It’s exciting that BeOne Medicines has decided to expand its manufacturing footprint in the United States and even more exciting that it chose New Jersey to build this major facility,” noted NJEDA Chief Executive Officer Evan Weiss. “The pharmaceutical industry has a long legacy in New Jersey, and Governor Sherrill is committed to ensuring we remain the medicine chest of the world. The Next New Jersey Manufacturing Program is helping bolster the state’s manufacturing and pharmaceutical industries, drive job creation, and strengthen our economy.”

BeOne Medicines is an oncology company focused on developing innovative therapies for hematologic and solid tumor cancers. The company develops and manufactures treatments for blood, lung, gastrointestinal, breast, gynecological, and rare cancers.

Recent Project Announcements

Ability Engineering Technology Modernizes-Plans South Holland-Chicago, Illinois, Operations

07/30/2026